FDA Accepts Eisai’s Supplemental New Drug Application (sNDA) to Update the Labeling for Anti-Obesity Agent BELVIQ
Eisai Inc. announced today that...
Read MoreEisai Inc. announced today that...
Read MoreBoehringer Ingelheim India have brought...
Read MoreBritish Biologicals, a global nutraceutical...
Read MoreEnzychem Lifesciences, Corp. (KOSDAQ: 183490)...
Read MoreBioAsia, the annual global life...
Read MoreA new study has found...
Read MoreDR 800* offers one solution...
Read MoreCertara®, the global leader in...
Read MoreAfter apprising India with ‘What...
Read More